Aquavit Pharmaceuticals
Aquavit Pharmaceuticals, Inc., located in New York City, is developing several innovative products and platform technology IP for personalized medicine. Aquavit's major innovation is a patented micro-channel® technology - a novel route of administration (RoA) for drugs and biologics. Micro-channel® technology allows for inter-dermal delivery, which has higher efficacy and speed of delivery for any drug or therapeutic agent currently delivered either topically or via a patch form. Applications for micro-channel® technology range from medical aesthetics, dermatology, infectious diseases to oncology. The company's mission is to modernize and personalize healthcare for patients through innovative drug and biologics delivery systems.